Skip to main content

Advertisement

Log in

Mediterranean leishmaniasis in HIV-infected patients: Epidemiological, clinical, and diagnostic features of 22 cases

  • Clinical and Epidemiological Studies
  • Originalia
  • Published:
Infection Aims and scope Submit manuscript

Summary

Twenty-two Italian HIV-infected patients developed leishmaniasis, clinically manifested as visceral (13 cases), cutaneous (2 cases) and disseminated disease (7 cases). Twenty were males and two females (mean age: 32.8 years) with a mean CD4+ cell count of 46.8/μl at diagnosis; risk factors were intravenous drug use (17 patients) and sexual behaviour (two bisexual, two homosexual, one heterosexual). All but one patient lived or travelled in hypoendemic Italian regions and other Mediterranean countries. Apart from the two patients with cutaneous leishmaniasis, the clinico-pathological and biological spectrum of the infection was often atypical, especially in patients with disseminated disease. The diagnosis was routinely made by direct recovery of parasites in biological specimens, mainly in bone marrow aspirate, whereas serology was negative or borderline in most of the patients. Among 17in vitro isolates,Leishmania infantum was the only species involved with previously undescribed isoenzyme patterns in two cases. Treatment with antimonials and other drugs showed only temporary clinical improvement in some patients. Relapses were the rule. Leishmaniasis confirms itself as an opportunistic infection in HIV-positive persons. Secondary chemoprophylaxis should be considered in cases of relapsing disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Alvar, J., Cañavate, C., Gutiérrez-Solar, B., Jiménez, M., Laguna, F., Lopez-Vélez, R., Molina, R., Moreno, J.:Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin. Microbiol. Rev. 10 (1997) 298–319.

    PubMed  CAS  Google Scholar 

  2. World Health Organization:Leishmania/HIV co-infection. Epidemiological analysis of 692 retrospective cases. Wkly. Epidemiol. Rec. 8 (1997) 49–54.

    Google Scholar 

  3. World Health Organization: Report on the consultative meeting onLeishmania/HIV co-infection [WHO/LEISH/95.35] WHO, Geneva (1995) 1–14.

    Google Scholar 

  4. Alvar, J.: Leishmaniasis and AIDS co-infection: the Spanish example. Parasitol. Today 10 (1994) 160–163.

    Article  PubMed  CAS  Google Scholar 

  5. Tremblay, M., Olivier, M., Bernier, M.:Leishmania and the pathogenesis of HIV infection. Parasitol. Today 12 (1996) 257–261.

    Article  PubMed  CAS  Google Scholar 

  6. Person, R. D., de Queiros Sousa, A.: Clinical spectrum of leishmaniasis. Clin. Infect. Dis. 22 (1996) 1–13.

    Google Scholar 

  7. Condom, M. A., Clotet, B., Sirera, G., Milla, F., Foz, M.: Asymptomatic leishmaniasis in the acquired immunodeficiency syndrome. Ann. Intern. Med. 111 (1989) 767–768.

    PubMed  CAS  Google Scholar 

  8. Pineda, J. A., Hernandez Quero, J., Gallardo, J. A., Lopez-Ruz, M. A., Martinez-Perez, M. A., Macias, J., Lissen, E.: Frequency of subclinical visceral leishmaniasis in HIV-1-infected patients in Spain. Eur. J. Clin. Microbiol. Infect. Dis. 15 (1996) 263–264.

    Article  PubMed  CAS  Google Scholar 

  9. Peters, B. S., Fish, D., Golden, R., Evans, D. A., Bryceson, A. D. M., Pinching, A. J.: Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy. Quart. J. Med. 283 (1990) 1101–1111.

    Google Scholar 

  10. Montalban, C., Calleja, J. L., Erice, A., Laguna, F., Clotet, B., Podzamczer, D., Cobo, J., Mallolas, J., Yebra, M., Gallego, A.: Visceral leishmaniasis in patients infected with human immunodeficiency virus. J. Infect. 21 (1990) 261–270.

    Article  PubMed  CAS  Google Scholar 

  11. Rosenthal, E., Merty, P., Poizot-Martin, I., Reynes, J., Pratlong, F., Lafeuillade, A., Jaubert, D., Boulet, D., Dereure, J., Gambarelli, F., Gastent, J. A., Dujardin, P., Dellamonica, P., Cassuto, J. P.: Visceral leishmaniasis and HIV-1 co-infection in Southern France. Trans. R. Soc. Trop. Med. Hyg. 89 (1995) 159–162.

    Article  PubMed  CAS  Google Scholar 

  12. Berman, J. D.: Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin. Infect. Dis. 24 (1997) 684–703.

    PubMed  CAS  Google Scholar 

  13. Gradoni, L., Bryceson, A., Desjeux, P.: Treatment of Mediterranean visceral leishmaniasis. Bull. World Health Organ. 73 (1995) 191–197.

    PubMed  CAS  Google Scholar 

  14. Amela, C., Lopez-Gay, D., Alberdi, J. C., Castilla, J.: Injecting drug use as risk factor for visceral leishmaniasis in AIDS patients. Eur. J. Epidemiol. 12 (1996) 91–92.

    Article  PubMed  CAS  Google Scholar 

  15. Herrera, E., Bosch, R. J., Fernandez, F., de Troya, M., Sanchez, P.: The presence and significance ofLeishmania in mucocutaneous biopsies from HIV+ patients with visceral leishmaniasis. Eur. J. Dermatol. 6 (1996) 501–504.

    Google Scholar 

  16. Gasser, I., Jaén, A., Gonzales, J., Ribera, E.: Diagnosis of visceral leishmaniasis in HIV-infected patients. Eur. J. Clin. Microbiol. Infect. Dis. 15 (1996) 967–968.

    Article  PubMed  CAS  Google Scholar 

  17. Gramiccia, M., Gradoni, L., Troiani, M.: HIV-Leishmania coinfection in Italy. Isoenzyme characterization ofLeishmania causing visceral leishmaniasis in HIV patients. Trans. R. Soc. Trop. Med. 86 (1992) 161–163.

    Article  CAS  Google Scholar 

  18. Pratlong, F., Dedet, P., Marty, P., Portus, M., Deniau, M., Dereure, J., Abranches, P., Reynes, J., Martini, A., Lefebvre, M., Rioux, J. A.:Leishmania-human immunodeficiency virus coinfection in the Mediterranean basin: isoenzymatic characterization of 100 isolates of theLeishmania infantum complex. J. Infect. Dis. 172 (1995) 323–326.

    PubMed  CAS  Google Scholar 

  19. Scaglia, M., Malfitano, A., Douville, H., Sacchi, P., Gatti, S., Gradoni, L., Gramiccia, M.: Dermonodular and visceral leishmaniasis due toLeishmania infantum with a new isoenzyme pattern: report of a case involving a patient with AIDS. Clin. Infect. Dis. 22 (1996) 376–377.

    PubMed  CAS  Google Scholar 

  20. Pratlong, F., Reynes, J., Dereure, J., Baixench, M. T., Marchou, B., Lefebvre, M., Janbon, F.: Characterization ofLeishmania isolates from two AIDS patients originating from Valencia, Spain. Trans. R. Soc. Trop. Med. Hyg. 87 (1993) 705–706.

    Article  PubMed  CAS  Google Scholar 

  21. Jimenez, M. J., Laguna, F., de la Torre, F., Solis, F., Pratlong, F., Alvar, J.: NewLeishmania infantum zymodemes responsible for visceral leishmaniasis in patients co-infected with HIV in Spain. Trans. R. Soc. Trop. Med. Hyg. 89 (1995) 33.

    Article  PubMed  CAS  Google Scholar 

  22. Gradoni, L., Scalone, A., Gramiccia, M., Troiani, M.: Epidemiological surveillance of leishmaniasis in HIV-1 infected individuals in Italy. AIDS 10 (1996) 785–791.

    Article  PubMed  CAS  Google Scholar 

  23. Pérez-Molina, J. A., Lopez-Vélez, R., Montilla, P., Guerrero, A.: Pentamidine isothionate as secondary prophylaxis against visceral leishmaniasis in HIV-positive patients. AIDS 10 (1996) 237–238.

    Article  PubMed  Google Scholar 

  24. Ribera, E., Ocaña, I., de Otero, J., Cortes, E., Gasser, I., Pahissa, A.: Prophylaxis of visceral leishmaniasis in human immunodeficiency virus infected patients. Am. J. Med. 100 (1996) 496–501.

    Article  PubMed  CAS  Google Scholar 

  25. Pérez-Molina, J. A., Lopez-Vélez, R., Guerrero, A.: Secondary prophylaxis for visceral leishmaniasis in HIV-infected individuals. Am. J. Med. 102 (1997) 132.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Agostoni, C., Dorigoni, N., Malfitano, A. et al. Mediterranean leishmaniasis in HIV-infected patients: Epidemiological, clinical, and diagnostic features of 22 cases. Infection 26, 93–99 (1998). https://doi.org/10.1007/BF02767767

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02767767

Keywords

Navigation